In a recent transaction, Corby C. Whitaker, the Senior Vice President of Sales and Marketing at Aspen Aerogels Inc . (NYSE:ASPN), sold 55,159 shares of the company's stock. The shares were sold at prices ranging from $24.75 to $25.24, with the total value of the sale amounting to approximately $1.38 million. This transaction was executed in multiple trades, as specified in a footnote of the filing, which also indicates that Whitaker is willing to provide full information regarding the number of shares sold at each separate price upon request.
In addition to the sale, Whitaker also acquired the same number of shares through the exercise of stock options at a price of $3.63 per share, totaling around $200,227. The options exercised are fully vested and exercisable, as noted in the footnotes of the report.
Following these transactions, Whitaker's direct ownership in Aspen Aerogels consists of 111,062 shares of Common Stock and 20,471 Restricted Stock Units, as detailed in the SEC filing. The remaining shares owned following the sale of stock indicate a diverse portfolio of holdings within the company.
Aspen Aerogels, a leader in the production of high-performance aerogel insulation, has seen its stock perform in various market conditions, and transactions like these are closely watched by investors seeking insights into executive confidence and company performance.
Investors and stakeholders in Aspen Aerogels can access the full details of these transactions by referring to the company's recent SEC Form 4 filing. This legal document provides transparency into the trading activities of the company's insiders, offering a glimpse into their investment moves and holdings.
InvestingPro Insights
As Aspen Aerogels Inc. (NYSE:ASPN) navigates the market, recent insider transactions have captured investor attention. To provide further context, InvestingPro data and tips offer additional insights into the company's financial health and stock performance. Aspen Aerogels boasts a notable market capitalization of $2 billion, with a striking revenue growth of 53.37% over the last twelve months as of Q1 2024. This growth is underscored by a quarterly revenue surge of 107.3% in Q1 2024, reflecting the company's expanding market reach and sales capabilities.
Despite the lack of profitability in the last twelve months, with a negative P/E ratio of -61.29 and an adjusted P/E ratio of -72.57, analysts are optimistic about Aspen Aerogels' sales growth in the current year. This sentiment is echoed by six analysts who have revised their earnings expectations upwards for the upcoming period, signaling potential upside for the stock. The company's stock has also demonstrated resilience with a substantial one-year price total return of 232.95%, which could reflect investor confidence in its long-term strategy and market position.
For those looking to delve deeper into Aspen Aerogels' prospects, InvestingPro offers additional insights. There are 16 more InvestingPro Tips available, including analysis on the company's liquidity, debt levels, and stock price volatility. For example, while the stock has experienced significant returns over various periods, the RSI suggests it is currently in overbought territory, and it is trading near its 52-week high. These factors could influence investment decisions and should be considered alongside the company's robust revenue growth and analysts' positive outlook.
To explore these insights further and to inform your investment strategy, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.